Observational studyScientific reports2020

Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study.

Omesh Goyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.